Moneris allows businesses to connect their customers with convenient payment solutions across industries like retail and food & drink.
The Ontario Institute for Regenerative Medicine (OIRM) is part of a community of researchers and organizations that are making world-leading scientific discoveries in stem cell and regenerative medicine.
Sheba Microsystems develops high-end MEMS sensors and actuators for use in tech products like miniature cameras — where they perform functions like autofocus. It also creates 3D touchscreen technology.
3DS is a personalized medicine company with a software platform based on the three-dimensional analysis of chromosomal signatures. The technology measures the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity in several cancers and Alzheimer's disease.
XOR Labs Toronto commercializes technologies developed by the University Health Network that have either been clinically validated or have promising research results. It focuses on the fields of organ transplantation and diseased organ treatment.
MaRS Innovation is an early-stage seed investment fund for companies and technologies that stem from its members – which span universities, hospitals and research institutes.
MolecuLight is developing a non-invasive optical technology that acquires images in a manner similar to standard point-and-shoot digital cameras.
Medicine by Design brings together more than 100 high-calibre researchers in a globally competitive hub focused on regenerative medicine and cell therapy. We generate and utilize leading-edge technological, experimental and computational approaches to make paradigm-shifting discoveries.
CIFAR is finding the root causes of human diseases, developing technology to improve quality of life, bridging the divide between rich and poor nations, and meeting our future energy needs.
Woodland Biofuels creates cellulosic ethanol from wood chips and other types of forestry and agricultural waste at half the cost of producing the gasoline its biofuel replaces.
Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets.
Triphase in-licenses clinically enabled oncology assets with high-value potential and develops them in a shared risk model to proof-of-concept, then out-licenses or sells the product to create value.
University Health Network includes Toronto General and Toronto Western Hospitals, Princess Margaret Cancer Centre, and Toronto Rehabilitation Institute.
The UHN office of Technology Development & Commercialization (TDC) works with research scientists and clinicians at the University Health Network to create new intellectual property and advance it towards innovative commercial applications.
The Structural Genomics Consortium is a public-private partnership to promote the development of new medicines by carrying out basic science of relevance to drug discovery.
Sigma Analysis & Management Ltd. is a portfolio management firm, specializing in alternative products and portfolio architecture for institutional investors.
Social Innovation Generation (SiG) is a group who believes that serious social problems can be solved. Our focus is on fostering social innovation to achieve impact, durability and scale by engaging the creativity and resources of all sectors.
RBC provides tailor-made, comprehensive banking and investment solutions to our clients.
Proteocyte Diagnostics is a Canadian molecular diagnostics company founded in August 2011.
Andover Capital Corporation is a Toronto based investment & holding company focused on acquiring and building great businesses.
Opalux is the pioneer of a broad range of colour changing materials.
The Ontario Institute for Cancer Research is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancer.
Ontario Genomics connects companies, researchers and policy-makers to support the early stages of genomics technologies’ move from the lab to solve real-world problems in the clinic and in industry.
Norton Rose Fulbright Canada is a member of Norton Rose Fulbright, a global legal practice with more than 3,800 lawyers based in over 50 cities worldwide.
The National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) supports small and medium-sized enterprises in Canada grow stronger, grow faster, grow bigger through innovation and technology.
The National Angel Capital Organization (NACO) accelerates a thriving, early-stage investing ecosystem in Canada by connecting individuals, groups and other partners that support angel-stage investing.
Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products.
ArcticDx is a molecular diagnostic company with a focus on commercializing genetic discoveries.
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company’s development cycle, from seed through expansion, with a focus on innovative technology-based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their markets.
Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health.